Investor Presentation

Investor Presentation - Q2FY27 - Revenue Rs 4,314 mn +52% YoY, +10% QoQ; EBITDA Rs 1,020 mn +50% YoY, +11% QoQ; EBITDA margin 23.6% - PAT Rs 485 mn +17% YoY; Cash Profits Rs 816 mn - Bed capacity 2,800+ beds; occupancy 72%; ARPOB Rs 35,948 +11% YoY - New hospitals contribute 28% of revenue mix; existing hospitals show 24% YoY revenue growth - Strategic investment by Advent with Rs 3,150 Cr primary capital infusion for 24.9% stake - Gurugram hospital (250 beds) expected operational by H1 FY28 with Rs 200 Cr outlay - Target to scale bed capacity to 7,000-8,000 in 3-5 years with Advent partnership - Strong 5-year CAGR: Revenue 39%, EBITDA 34%, PAT 54% - Focus on high-value specialties, robotics, oncology, and transplants driving ARPOB and margins